ImportRefusal LogoImportRefusal

GLAXO SMITHKLINE PHARMACEUTICALS

⚠️ High Risk

FEI: 3029749557 • New Nelhi • INDIA

FEI

FEI Number

3029749557

📍

Location

New Nelhi

🇮🇳

Country

INDIA
🏢

Address

Gate No 5 Bharat Yuvak, , New Nelhi, , India

High Risk

FDA Import Risk Assessment

52.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

1
Total Refusals
1
Unique Violations
12/28/2023
Latest Refusal
12/28/2023
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
11.2×30%
Recency
58.7×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
12/28/2023
56BCB03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is GLAXO SMITHKLINE PHARMACEUTICALS's FDA import refusal history?

GLAXO SMITHKLINE PHARMACEUTICALS (FEI: 3029749557) has 1 FDA import refusal record(s) in our database, spanning from 12/28/2023 to 12/28/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GLAXO SMITHKLINE PHARMACEUTICALS's FEI number is 3029749557.

What types of violations has GLAXO SMITHKLINE PHARMACEUTICALS received?

GLAXO SMITHKLINE PHARMACEUTICALS has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GLAXO SMITHKLINE PHARMACEUTICALS come from?

All FDA import refusal data for GLAXO SMITHKLINE PHARMACEUTICALS is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.